Michael J. Millward

7.0k citations
42 papers · 5.7k · 3 hit papers · h-index 25

Impact in

  • Oncology top 1%
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies

Papers in

    • Cutaneous Melanoma Detection and Management 5
    • HER2/EGFR in Cancer Research 5
    • CAR-T cell therapy research 3
    • Cancer Treatment and Pharmacology 2
    • Colorectal Cancer Treatments and Studies 2
    • Melanoma and MAPK Pathways 16

Michael J. Millward

42 papers receiving 5.5k citations

Michael J. Millward's Hit Papers

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial 2012 · 2.5k citations
2.5k0+7+15Years since publication50010001.5k2.0k2.5k

Peers

Michael J. Millward
Comparison fields: 5 of 109
  • Oncology 2.6k
  • Otorhinolaryngology 191
  • Pulmonary and Respiratory Medicine 1.2k
  • Molecular Biology 2.7k
  • Cancer Research 475
Replace Ralph Zinner with:
Ralph Zinner United States
Drew Warren Rasco United States
Helen Swaisland United Kingdom
Angela Zubel United States
Albiruni R. Abdul Razak Canada
Carolyn D. Britten United States
Anna Spreafico Canada
Rastislav Bahleda France
Christina S. Baik United States
Rosella Silvestrini Italy
Michael J. Millward relative to Ralph Zinner United States Ralph Zinner's profile →
Citations per field
00.5×1.7×
Ralph Zinner · 1×
Citations per year

Countries citing papers authored by Michael J. Millward

Since Specialization
Citations

This map shows the geographic impact of Michael J. Millward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Millward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Millward more than expected).

Fields of papers citing papers by Michael J. Millward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Millward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Millward. The network helps show where Michael J. Millward may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Millward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Millward Line = papers co-authored together Michael J. Millward links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Hit paper breakdown →
20122523
2
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
Hit paper breakdown →
2003810
3
Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group
Hit paper breakdown →
2006505
4 1996236
5 2005231
6 2014182
7 2007161
8 2014118
9 200395
10 201492
11 200478
12 202059
13 201253
14 202050
15 200650
16 200648
17 199747
18 201443
19 200942
20 201235

About Michael J. Millward

Michael J. Millward is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Cancer Research, having authored 42 papers that have together received 5.7k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (16 papers), Cutaneous Melanoma Detection and Management (5 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Treatments and Mutations (5 papers), CAR-T cell therapy research (3 papers), Head and Neck Cancer Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (2.6k citations), Otorhinolaryngology (191 citations), Pulmonary and Respiratory Medicine (1.2k citations), Molecular Biology (2.7k citations) and Cancer Research (475 citations). Michael J. Millward has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Frank V. Fossella, Karin V. Mattson, Jose R. Pereira, Vera A. Gorbounova, Joachim von Pawel, Rodryg Ramlau, Chandra Prakash Belani, Aleksandra Szczęsna, Eckhard Kaukel and Anna Pluzanska. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Pathology and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact